AlphaCrest Capital Management’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-36,333
Closed -$285K 1423
2022
Q2
$285K Buy
36,333
+16,957
+88% +$146K 0.01% 1133
2022
Q1
$215K Sell
19,376
-13,352
-41% -$150K 0.01% 1193
2021
Q4
$575K Buy
32,728
+10,761
+49% +$209K 0.02% 1049
2021
Q3
$445K Sell
21,967
-15,820
-42% -$407K 0.02% 965
2021
Q2
$1.25M Buy
+37,787
New +$1.43M 0.05% 551

Other funds holding ONEM

AlphaCrest Capital Management's ONEM Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 36,333 shares — an estimated $285K sold.

AlphaCrest Capital Management first reported a position in ONEM in Q2 2021 and held it in 5 quarters. The position peaked at $1.25M in Q2 2021. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 36,333 1Life Healthcare shares in Q3 2022, an estimated $285K.
  • AlphaCrest Capital Management first reported a position in 1Life Healthcare in Q2 2021 and held it in 5 quarters.
  • AlphaCrest Capital Management's 1Life Healthcare position peaked at $1.25M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.